---
layout: minimal-medicine
title: Bosentan
---

# Bosentan
### Generic Name
Bosentan

### Usage
Bosentan is primarily used to treat pulmonary arterial hypertension (PAH), a serious condition where blood pressure in the arteries leading to the lungs becomes abnormally high.  It's approved for use in adults and children aged 3 years and older with idiopathic or congenital PAH.  The drug improves exercise ability and helps prevent the condition from worsening.  Bosentan works by widening the blood vessels in the lungs, thereby reducing the pressure.

While not its primary indication, Bosentan has also been used off-label to treat Raynaud phenomenon and digital ulcers associated with systemic sclerosis.  These uses are based on the drug's ability to improve blood flow in small blood vessels.  However, it's crucial to note that these uses are not formally supported by regulatory approvals and should only be considered under the strict guidance of a physician.

### Dosage

**Adults:**

* **Pulmonary Arterial Hypertension (PAH):** The usual starting dose is 62.5 mg twice daily (BID).  After four weeks, the dose may be increased to 125 mg BID for patients weighing 40 kg or more. For patients weighing less than 40 kg, the dose remains at 62.5 mg BID.  The maximum dose is 125 mg BID.  When discontinuing, a gradual reduction to 62.5 mg BID for 3-7 days is recommended before stopping completely.

* **Off-label uses (Raynaud phenomenon and digital ulcers in systemic sclerosis):**  The usual starting dose is 62.5 mg BID for four weeks, gradually increased to 125 mg BID.

**Children:**

Dosage for children with PAH varies significantly based on age and weight. Itâ€™s crucial to follow a healthcare provider's precise instructions.  Generally, a physician will determine the appropriate dose, starting with lower amounts and gradually increasing as tolerated.  Alternative dosing regimens are available for children 3 years and older, typically using weight-based calculations.

**Important Considerations:**  Dosage adjustments are necessary in individuals with hepatic impairment.  Patients with moderate to severe hepatic impairment should generally not use Bosentan due to significantly increased systemic exposure.  Renal impairment does not typically necessitate a dosage adjustment.  

**Administration:** Bosentan is usually administered orally in tablet form. The tablets for oral suspension can be dispersed in water before administration.

### Side Effects

**Common Side Effects (occurring in more than 10% of patients):**

* Headache
* Edema (swelling)
* Increased levels of liver enzymes (ALT and AST)
* Respiratory tract infection

**Less Common but Serious Side Effects (occurring in less than 10% of patients):**

* Chest pain
* Syncope (fainting)
* Flushing
* Hypotension (low blood pressure)
* Palpitations
* Fluid retention
* Anemia
* Arthralgia (joint pain)
* Sinusitis


**Rare but Potentially Serious Side Effects (post-marketing reports and case studies):**

* Anaphylaxis
* Angioedema
* DRESS syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms)
* Hepatic cirrhosis (with prolonged use)
* Hepatic failure
* Hypersensitivity reactions
* Jaundice
* Leukopenia
* Neutropenia
* Severe anemia
* Skin rash
* Thrombocytopenia

If you experience any adverse effects, particularly those listed above, consult your healthcare provider immediately.

### How it Works

Bosentan is an endothelin receptor antagonist.  Endothelin is a substance that causes blood vessels to constrict. By blocking the action of endothelin at its receptors (ETA and ETB), Bosentan prevents the constriction of blood vessels, particularly in the lungs.  This leads to widening of the blood vessels, lowering blood pressure in the pulmonary arteries, and improving blood flow to the lungs.

### Precautions

* **Pregnancy:** Bosentan is categorized as Pregnancy Category X, meaning it poses significant risks to a developing fetus.  It's absolutely contraindicated in pregnancy and during breastfeeding. Women of childbearing age must use two reliable forms of birth control during treatment and for one month afterward.  Pregnancy tests are required monthly.

* **Hepatic Impairment:** Bosentan can cause liver damage (hepatotoxicity). Regular monitoring of liver function tests (LFTs) is essential. The drug is contraindicated in individuals with moderate to severe hepatic impairment.  Dosage adjustments may be necessary in those with mild hepatic impairment.

* **Interactions:**  Bosentan interacts with many other medications, including antifungal drugs, contraceptives, HMG-CoA reductase inhibitors, phosphodiesterase-5 inhibitors, and vitamin K antagonists.  Consult a healthcare provider about potential interactions if you're taking other medications.  The drug is contraindicated with several other medications. See the detailed information for complete list.

* **Other Precautions:**  Bosentan should be used cautiously in patients with underlying heart failure or conditions that could be worsened by fluid retention.


### FAQs

**Q: Can I take Bosentan with food?**  A: Yes, Bosentan can be taken with or without food.

**Q: How should I store Bosentan?** A: Store Bosentan at room temperature, away from moisture and direct sunlight.  Follow the specific storage instructions provided with your medication.

**Q: What should I do if I miss a dose?** A:  Take the missed dose as soon as you remember unless it's close to the time for your next dose. Don't double the dose to make up for a missed dose. Consult your healthcare provider for guidance.

**Q:  Is Bosentan safe for long-term use?** A: While Bosentan can be used for long-term management of PAH, regular monitoring of liver function and other potential side effects is crucial to ensure safety.  The risks and benefits should be continually evaluated by a physician.

**Q:  Are there any alternatives to Bosentan?** A: Yes, there are other medications available for PAH and related conditions. A healthcare provider can help determine the most suitable treatment option based on individual needs and health status.


**Disclaimer:** This information is intended for educational purposes only and should not be considered medical advice.  Always consult with a qualified healthcare professional before starting or changing any medication.  The information provided here is a summary and may not include all possible side effects, drug interactions, or precautions. Always refer to the official prescribing information for complete details.
